Spain's clinical diagnostic market was valued at $1.3 Bn in 2022 and is estimated to expand at a CAGR of 5% from 2022-30 and will reach $1.9 Bn in 2030. One of the main reasons propelling the growth of this market is an increase in chronic disease and government support. The market is segmented by type, drug, and distribution channel. Some key players in this market are Abbott, BD, bioMérieux SA, Bio-Rad Laboratories, Danaher Corporation, Siemens AG, Hologic, Qiagen NV, Quest Diagnostics, F. Hoffmann-La Roche Ltd, Eurofins Megalab, Werfen Group, Grifols and others.
The Spain clinical diagnostic market was valued at $1.3 Bn in 2022 and is estimated to expand at a CAGR of 5% from 2022-30 and will reach $1.9 Bn in 2030. In Spain, the clinical diagnostics market is rapidly expanding, with a high need for improved diagnostic technology and solutions. The clinical diagnostics market in Spain is expanding, with numerous laboratory tests used to diagnose and monitor disorders. This market is divided into various sectors, including in-vitro diagnostics (IVD), medical imaging, and clinical laboratory services. The growing demand for reliable and quick diagnostic services, the increasing frequency of chronic diseases, and the rising healthcare spending are driving the expansion of the clinical laboratory services market in Spain. Overall, the clinical diagnostics industry in Spain is likely to expand further.
Market Growth Drivers
The population in Spain is aging, which is leading to an increase in the incidence of age-related diseases. For example, the prevalence of Alzheimer's disease is increasing, with an estimated 700,000 cases in 2021 (Alzheimer's Association Spain). This is driving the demand for diagnostic tests for early detection and diagnosis. There is a growing demand for point-of-care testing (POCT) in Spain, which allows for rapid and accurate diagnosis at the point of care, without the need for laboratory testing. The market for POCT in Spain was valued at $149.6 Mn in 2020, and it is expected to grow at a CAGR of 5.5% from 2021 to 2028. The incidence of chronic diseases such as diabetes, cancer, and cardiovascular diseases is increasing in Spain, which is driving the demand for diagnostic tests. For example, the prevalence of diabetes in Spain was estimated to be 14.1% in 2019, and it is expected to increase to 15.6% by 2045 (International Diabetes Federation). Similarly, the incidence of cancer is also increasing, with an estimated 277,234 new cases in 2020 (Spanish Society of Medical Oncology).
Advances in technology, such as automation and digitization, are improving the accuracy and efficiency of diagnostic tests in Spain. For example, the adoption of digital pathology systems is increasing, which allows for the remote viewing and analysis of tissue samples. The market for digital pathology in Spain was valued at $26.7 Mn in 2020, and it is expected to grow at a CAGR of 9.8% from 2021 to 2028. The healthcare expenditure in Spain is increasing, which is driving the demand for diagnostic tests. The healthcare expenditure in Spain was estimated to be $88.6 Bn in 2020, and it is expected to grow at a CAGR of 3.6% from 2021 to 2028.
There is a shortage of skilled professionals, such as laboratory technicians and pathologists, in Spain. This can lead to delays in test results and a backlog of samples. In 2019, it was estimated that Spain had a shortage of approximately 4,000 laboratory technicians (International Federation of Biomedical Laboratory Science). The regulatory environment for diagnostic tests in Spain is complex and can be challenging for companies to navigate. The regulations can vary depending on the type of test and the intended use. This can create delays in the approval process and increase the costs associated with bringing a new test to market. The clinical diagnostics market in Spain is highly competitive, with a large number of local and international players. This can make it difficult for new entrants to gain market share and compete with established players.
In 2020, Roche, Siemens Healthineers, and Abbott Laboratories were the top players in the Spain clinical diagnostics market. The COVID-19 pandemic has created significant challenges for the clinical diagnostics market in Spain, with disruptions to supply chains, changes in testing demand, and delays in regulatory approvals. In 2020, the COVID-19 pandemic led to a decline in the overall clinical diagnostics market in Spain, with a contraction of 6.7% compared to the previous year.
The regulatory framework for clinical diagnostics in Spain is based on the European Union (EU) regulations for medical devices. In addition, diagnostic tests must be performed in accordance with good laboratory practices and must meet certain quality standards. The healthcare policy in Spain is focused on providing universal healthcare coverage to all citizens. The healthcare system in Spain is decentralized, with responsibility for healthcare delivery shared between the national government and the 17 autonomous regions. The government funds the majority of healthcare services, and patients are required to make co-payments for certain services.
Spanish Agency of Medicines and Medical Devices (AEMPS) is responsible for the regulation and approval of diagnostic tests in Spain. It ensures that all tests meet the required safety and efficacy standards. Diagnostic tests are classified into different categories based on their risk level, and companies must obtain approval from the AEMPS before selling their tests in Spain.
The Ministry of Health is responsible for the overall healthcare policy in Spain, including the regulation of clinical diagnostics. It sets the strategic direction for healthcare policy and oversees the implementation of regulations.
The Spanish Society of Clinical Biochemistry and Molecular Pathology (SEQC) is a professional organization that promotes the development and quality of clinical diagnostics in Spain. It provides guidelines for good laboratory practices and collaborates with regulatory agencies to develop regulations.
In Spain, reimbursement for diagnostic tests is primarily provided by the National Health System (NHS), which is funded by the government. The reimbursement rates for diagnostic tests are established by the Interterritorial Council of the National Health System, which is composed of representatives from the central government and the autonomous regions. The reimbursement scenario for diagnostic tests in Spain can be complex and often varies depending on the type of test, the intended use, and the healthcare setting. In general, the reimbursement rates for diagnostic tests in Spain are lower than in other European countries, such as Germany and France.
The reimbursement process in Spain involves several steps. First, a company must obtain approval from the Spanish Agency of Medicines and Medical Devices (AEMPS) for its diagnostic test. Once the test is approved, the company must apply for inclusion of the test in the NHS's Common Portfolio of Services (Cartera de Servicios Comunes del Sistema Nacional de Salud).
1. Executive Summary
1.1 Service Overview
1.2 Global Scenario
1.3 Country Overview
1.4 Healthcare Scenario in Country
1.5 Healthcare Services Market in Country
1.6 Recent Developments in the Country
2. Market Size and Forecasting
2.1 Market Size (With Excel and Methodology)
2.2 Market Segmentation (Check all Segments in Segmentation Section)
3. Market Dynamics
3.1 Market Drivers
3.2 Market Restraints
4. Competitive Landscape
4.1 Major Market Share
4.2 Key Company Profile (Check all Companies in the Summary Section)
126.96.36.199 Product Applications and Services
188.8.131.52 Recent Developments
184.108.40.206 Partnerships Ecosystem
220.127.116.11 Financials (Based on Availability)
5. Reimbursement Scenario
5.1 Reimbursement Regulation
5.2 Reimbursement Process for Services
5.3 Reimbursement Process for Treatment
6. Methodology and Scope
By End User (Revenue, USD Bn)
Insights10 will provide you with the reports within 10 key parameters which are:
Based on our many years of experience, we believe that these are the parameters that are critical to decision-making for business stakeholders. Our focused approach to developing reports focused on 10 key parameters, enabled us to arrive at the name “Insights10”.
Stage I: Market Data Collection
Primary Interviews: We have developed a network of experts, freelancers, and researchers across countries through which we engage with local experts to gather key data points and assumptions about each market. We also engage regularly with some of the best market research agencies such as Atheneum, GuidePoint, GLG, etc. to conduct surveys and interviews, and build intelligence. We have language translators as a part of our team, who between them can cover 30+ languages allowing us to extract better local insights.
Secondary Data Collection: We have developed strong expertise and experience in secondary data collection methods for developing unique data sets and research material. We gather data from multiple reliable sources to maintain a high level of accuracy and consistency. The market data is analyzed and forecasted using appropriate statistical and coherent models. The report offers an overall analysis of the market size, growth, and market share as well as a segment-level analysis of the specific market. Our report includes precise, to-the-point information related to the overall market, competition, growth drivers, challenges, regulatory updates, and competition.
Data Sources: We have access to multiple highly reliable free and subscription data sources. We have many years of experience to understand which sources are more dependable for what and which to prefer for the reliable and latest information. The key sources of information include the following, but are not limited to:
Stage II: Market Data Analysis and Statistical Model
Market Trends: We generally look at macro parameters and micro indicators. The macro parameters include changes in government policies, demand and supply of the market, government intervention programs, and major market share. The micro indicators are GDP growth, market size, market volume, etc. We also understand nuances specific to each country like the US, Canada, India, Germany, etc., and have worked across 60+ countries and hence not only understand global trends but how these differ by country, how payment models, market structure, cultural parameters, etc. differ in each country.
Market Sizing and Analysis: Our expert data analytics team has created various market forecast models by employing the top-down approach i.e. starting with the large overall market and segmenting different areas and the bottom-up approach i.e. starting with population and epidemiology and rolling up based on spend, etc., estimating the size of the market, and distributing among the geographic and/or product segments.
The top-down approach is mainly used for new product forecasting and the bottom-up approach is used for demand estimation of any product for different countries summed up to form the total market. We are able to round off insights and build stronger forecasts because we always do both these methods and triangulate the final numbers.
The study on the market covers the analysis of the leading geographies such as Asia-Pacific, Africa, Europe, Middle East, North America, and Latin America for the period of 2022 to 2030. The qualitative analysis covers the industry landscape and trends, market opportunities, competitive landscape, and policy and regulatory scenario, and the quantitative analysis covers different market estimates and forecasts.
Data Triangulation & Validation:
Data triangulation of various sources and results of the research are carried out by benchmarking with reliable sources such as industry statistics, statistical databases, and company-level averages, etc.
We make sure to finalize the numbers in alignment with the market research. Firstly, our internal experts ensure thorough validation and checking to ensure accurate and precise analysis and then validation is also done using a multiple-data analysis model. Two-level validation is done and entails the finalization of the report scope and the way of representation pattern.
Stage III: Interpretation and Presentation
Analysis & Interpretation: The information gathered is then analyzed and synthesized. The second series of interviews are done if necessary to check and validate. The future opportunities are analyzed by understanding product commercialization and many other factors. It also comprises the analysis of data discrepancies observed across various data sources. Information procured from secondary and primary results is then, interpreted by considering the following parameters: (a partial list)
Insights: Our reports deliver actionable insights backed with supporting facts and figures to assist you in achieving exemplary growth. Our in-depth analyses are interspersed with relevant insights and statistics to oﬀer an executive-level view of a given market. The description helps in correlating many minor factors affecting the market and their impact on the different segments within the market.
Data curated from the analysis and interpretation are drawn to portray all in one consolidated report.
Presentation & Reporting: The market research report is presented in different forms such as charts by using a scientific approach for easy understanding. Historic, current, and future analysis is provided for each market in terms of both value and volume. The size of the market is interpreted in the US Dollar value and the respective unit, based on the product, for volume consumption.
The foreign exchange rates are calculated on the respective dates and for the respective regions covered in the study.
We value your inquiry and offer free customization with every report to fulfil your exact research needs.
This report addresses